4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-17-023171
Options or other derivatives
- Director acquired 6,844 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-03-24 | Grant or award : show line 1 in the form Stock Option (right to buy) | +6,844 | 6,844 | D |
Loading xslF345X03/doc4.xml…